Literature DB >> 11714588

Acetylcodeine, an impurity of illicitly manufactured heroin, elicits convulsions, antinociception, and locomotor stimulation in mice.

C L O'Neal1, A Poklis, A H Lichtman.   

Abstract

Acetylcodeine is one of the major impurities present in illicitly manufactured heroin (diacetylmorphine). Data on its pharmacology and toxicology are limited and its ability to alter the toxic effects of diacetylmorphine is not known. The first objective of the present study was to compare the acute pharmacological and toxicological effects of acetylcodeine to those of codeine and diacetylmorphine in mice by assessing nociception in the tail-flick test, locomotor stimulation, and convulsive behavior. The second goal of this study was to determine whether acetylcodeine would alter the convulsant effects of diacetylmorphine. The antinociceptive potencies of acetylcodeine and codeine were similar, as reflected by their ED50 (95% confidence limits) values of 35 (29-44) and 51 (40-65) micromol/kg, respectively. Acetylcodeine was somewhat less potent than codeine in stimulating locomotor behavior, with ED50 values of 28 (22-37) and 12 (6-24) micromol/kg, respectively. Diacetylmorphine was considerably more potent than the other two drugs, producing antinociception and locomotor stimulation at ED50 values of 2.4 (1.4-4.1) and 0.65 (0.36-1.2) micromol/kg, respectively. On the other hand, the convulsant effects of acetylcodeine (ED50=138 (121-157) micromol/kg) and diacetylmorphine (ED50=115 (81-163) micromol/kg) were similar in potency and both were more potent than codeine (ED50=231 (188-283) micromol/kg). Finally, a subthreshold dose of acetylcodeine (72 micromol/kg) decreased the convulsant ED50 dose of diacetylmorphine to 40 (32-49). These findings suggest that the convulsant effects of acetylcodeine are more potent than predicted by its effects on locomotor activity and antinociception. The observation that acetylcodeine potentiated the convulsant effects of diacetylmorphine suggests a mechanism for some of the heroin-related deaths reported in human addicts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714588     DOI: 10.1016/s0376-8716(01)00145-4

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  6 in total

Review 1.  Seizures, illicit drugs, and ethanol.

Authors:  John C M Brust
Journal:  Curr Neurol Neurosci Rep       Date:  2008-07       Impact factor: 5.081

2.  In vitro development of embryos from experimentally Kerack-addicted Mice.

Authors:  Elham Mohammadzadeh; Fatemeh-Sadat Amjadi; Mansoureh Movahedin; Zahra Zandieh; Zohreh Nazmara; Neda Eslahi; Peymaneh Shirinbayan; Hamid Reza Asgari; Nahid Azad; Maryam Salimi; Morteza Koruji
Journal:  Int J Reprod Biomed       Date:  2017-07

3.  A Surface-Enhanced Raman Spectral Library of Important Drugs Associated With Point-of-Care and Field Applications.

Authors:  Stuart Farquharson; Carl Brouillette; Wayne Smith; Chetan Shende
Journal:  Front Chem       Date:  2019-10-25       Impact factor: 5.221

4.  Trace residue identification, characterization, and longitudinal monitoring of the novel synthetic opioid β-U10, from discarded drug paraphernalia.

Authors:  Henry West; John L Fitzgerald; Katherine L Hopkins; Michael G Leeming; Matthew DiRago; Dimitri Gerostamoulos; Nicolas Clark; Paul Dietze; Jonathan M White; James Ziogas; Gavin E Reid
Journal:  Drug Test Anal       Date:  2022-05-23       Impact factor: 3.234

5.  Component analysis of Iranian crack; a newly abused narcotic substance in iran.

Authors:  Ali Farhoudian; Mandana Sadeghi; Hamid Reza Khoddami Vishteh; Babak Moazen; Monir Fekri; Afarin Rahimi Movaghar
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

6.  Beneficial effects of Bacopa monnieri extract on opioid induced toxicity.

Authors:  Muhammad Shahid; Fazal Subhan; Ihsan Ullah; Gowhar Ali; Javaid Alam; Rehmat Shah
Journal:  Heliyon       Date:  2016-02-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.